| Dr Andrew Kikuta, MD | |
|
226 Bluebell Rd, Cedar Falls, IA 50613-6328 | |
| (319) 575-5800 | |
| (319) 575-5855 |
| Full Name | Dr Andrew Kikuta |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 7 Years |
| Location | 226 Bluebell Rd, Cedar Falls, Iowa |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1750860888 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | MD-48005 (Iowa) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mercyone Waterloo Medical Center | Waterloo, IA | Hospital |
| Sartori Memorial Hospital, Inc | Cedar falls, IA | Hospital |
| The Suites At Western Home Communities | Cedar falls, IA | Nursing home |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Covenant Medical Center Inc | 0244148732 | 211 |
News Archive
A large prospective study of 5033 men and women in the Troms- Study in northern Norway has reported that moderate wine consumption is independently associated with better performance on cognitive tests. The subjects (average age 58 and free of stroke) were followed over 7 years during which they were tested with a range of cognitive function tests.
Chimerix, Inc., a pharmaceutical company developing orally-available broad spectrum antiviral therapeutics, today announced the completion of a $45 million Series F financing. New Leaf Venture Partners led the round, with participation by new investors Pappas Ventures and Morningside Group, as well as existing investors Canaan Partners, Sanderling Ventures, Alta Partners, Asset Management Company and Frazier Healthcare Ventures.
Accelerate Brain Cancer Cure and Exosome Diagnostics are collaborating with leading academic medical centers to accelerate clinical validation of Exosome's blood and cerebrospinal fluid-based molecular diagnostics technology in brain cancer.
Researchers at the Universitat Autònoma de Barcelona with the collaboration of the Institute for Bioengineering of Catalonia, led by the professor of the UAB Department of Genetics and Microbiology Esther Julián, announced one year ago that the cells of the Mycobacterium brumae offer an improved alternative to current bladder cancer treatments such as BCG (an immunotherapy based on the Mycobacterium bovis), which can cause infections.
A unique combination of liver targeted radioactive microspheres (SIR-Spheres) and a standard-of-care systemic agent (Sorafenib) appears to confer a survival benefit for patients with inoperable primary hepatocellular cancer including those with disease that has spread outside the liver, according to the results of a prospective clinical study presented today at the 46th American Society of Clinical Oncology conference.
› Verified 8 days ago
| Entity Name | Covenant Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548288160 PECOS PAC ID: 0244148732 Enrollment ID: O20031111000534 |
News Archive
A large prospective study of 5033 men and women in the Troms- Study in northern Norway has reported that moderate wine consumption is independently associated with better performance on cognitive tests. The subjects (average age 58 and free of stroke) were followed over 7 years during which they were tested with a range of cognitive function tests.
Chimerix, Inc., a pharmaceutical company developing orally-available broad spectrum antiviral therapeutics, today announced the completion of a $45 million Series F financing. New Leaf Venture Partners led the round, with participation by new investors Pappas Ventures and Morningside Group, as well as existing investors Canaan Partners, Sanderling Ventures, Alta Partners, Asset Management Company and Frazier Healthcare Ventures.
Accelerate Brain Cancer Cure and Exosome Diagnostics are collaborating with leading academic medical centers to accelerate clinical validation of Exosome's blood and cerebrospinal fluid-based molecular diagnostics technology in brain cancer.
Researchers at the Universitat Autònoma de Barcelona with the collaboration of the Institute for Bioengineering of Catalonia, led by the professor of the UAB Department of Genetics and Microbiology Esther Julián, announced one year ago that the cells of the Mycobacterium brumae offer an improved alternative to current bladder cancer treatments such as BCG (an immunotherapy based on the Mycobacterium bovis), which can cause infections.
A unique combination of liver targeted radioactive microspheres (SIR-Spheres) and a standard-of-care systemic agent (Sorafenib) appears to confer a survival benefit for patients with inoperable primary hepatocellular cancer including those with disease that has spread outside the liver, according to the results of a prospective clinical study presented today at the 46th American Society of Clinical Oncology conference.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Andrew Kikuta, MD 226 Bluebell Rd, Cedar Falls, IA 50613-6328 Ph: (319) 575-5800 | Dr Andrew Kikuta, MD 226 Bluebell Rd, Cedar Falls, IA 50613-6328 Ph: (319) 575-5800 |
News Archive
A large prospective study of 5033 men and women in the Troms- Study in northern Norway has reported that moderate wine consumption is independently associated with better performance on cognitive tests. The subjects (average age 58 and free of stroke) were followed over 7 years during which they were tested with a range of cognitive function tests.
Chimerix, Inc., a pharmaceutical company developing orally-available broad spectrum antiviral therapeutics, today announced the completion of a $45 million Series F financing. New Leaf Venture Partners led the round, with participation by new investors Pappas Ventures and Morningside Group, as well as existing investors Canaan Partners, Sanderling Ventures, Alta Partners, Asset Management Company and Frazier Healthcare Ventures.
Accelerate Brain Cancer Cure and Exosome Diagnostics are collaborating with leading academic medical centers to accelerate clinical validation of Exosome's blood and cerebrospinal fluid-based molecular diagnostics technology in brain cancer.
Researchers at the Universitat Autònoma de Barcelona with the collaboration of the Institute for Bioengineering of Catalonia, led by the professor of the UAB Department of Genetics and Microbiology Esther Julián, announced one year ago that the cells of the Mycobacterium brumae offer an improved alternative to current bladder cancer treatments such as BCG (an immunotherapy based on the Mycobacterium bovis), which can cause infections.
A unique combination of liver targeted radioactive microspheres (SIR-Spheres) and a standard-of-care systemic agent (Sorafenib) appears to confer a survival benefit for patients with inoperable primary hepatocellular cancer including those with disease that has spread outside the liver, according to the results of a prospective clinical study presented today at the 46th American Society of Clinical Oncology conference.
› Verified 8 days ago
Khushman Dodd, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 5100 Prairie Pkwy Ste 301, Cedar Falls, IA 50613 Phone: 319-277-1990 Fax: 319-222-2999 | |
Dr. Jayasakthi Palaniappan, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 226 Bluebell Rd, Cedar Falls, IA 50613 Phone: 319-575-5800 | |
Ryan Neuhaus, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 5100 Prairie Pkwy Ste 205, Cedar Falls, IA 50613 Phone: 319-222-2711 | |
Dr. John Mark Zehr, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1227 W 27th St, Cedar Falls, IA 50614 Phone: 319-273-2009 Fax: 319-273-7030 | |
Dr. Kelly Jay Schmidt, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 5100 Prairie Pkwy Ste 101, Cedar Falls, IA 50613 Phone: 319-553-0828 Fax: 319-277-7548 | |
Susan L Woo, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2624 Orchard Dr, Cedar Falls, IA 50613 Phone: 319-277-1990 Fax: 319-277-0572 | |
Dr. Julie Renee Sandell, D.O.,F.P. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 226 Bluebell Rd, Cedar Falls, IA 50613 Phone: 319-575-5800 Fax: 319-575-5855 |